StonvexLoading…
StonvexStonvexStonvexCore line items from PAVM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-11 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $99.96K | $22.00K | $71.00K | $19.00K | $14.00K |
Operating Income | Not available | $-8.04M | $-21.81M | $-15.00M | $-10.16M |
Net Income | Not available | $-60.00K | $401.00K | $1.66M | $7.05M |
EPS (Diluted) | $-0.68 | $-4.42 | $-5.63 | $-0.11 | $0.13 |
Total Assets | Not available | $45.42M | $38.81M | $38.07M | $43.89M |
Total Liabilities | Not available | $20.43M | $16.51M | $12.28M | $12.47M |
Cash & Equivalents | Not available | $6.46M | $1.54M | $3.10M | $4.00M |
Free Cash Flow OCF − CapEx | Not available | $-2.64M | $-5.24M | $-3.67M | $-2.77M |
Shares Outstanding | Not available | 6.27M | 927.93K | 23.05M | 20.14M |